# Cannabioids as a New Intervention for Amphetamine Dependence

> **NCT02952196** · PHASE2 · WITHDRAWN · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)**

## Conditions studied

- Amphetamine Addiction

## Interventions

- **DRUG:** drug administration

## Key facts

- **NCT ID:** NCT02952196
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-11
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding
- **Last updated:** 2020-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02952196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02952196, "Cannabioids as a New Intervention for Amphetamine Dependence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02952196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*